Wei‐Chung Chiang
Impact in
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Mitochondrial Function and Pathology 3
- RNA modifications and cancer 2
-
- Autophagy in Disease and Therapy 7
- Co-authors
- Beth Levine (4 shared papers)Yongjie Wei (4 shared papers)Prashant Mishra (1 shared paper)Rhea Sumpter (1 shared paper)Ao‐Lin Hsu (3 shared papers)Tsui‐Ting Ching (2 shared papers)Zhongju Zou (2 shared papers)Carol Mousigian (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Cell (2 papers)IUBMB Life (1 paper)Clinical Cancer Research (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesTaiwanSpain
In The Last Decade
Wei‐Chung Chiang
12 papers receiving 1.7k citations
Wei‐Chung Chiang's Hit Papers
Peers
Comparison fields: 5 of 99
- Aging 270
- Geriatrics and Gerontology 96
- Epidemiology 810
- Physiology 85
- Molecular Biology 940
Countries citing papers authored by Wei‐Chung Chiang
This map shows the geographic impact of Wei‐Chung Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chung Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chung Chiang more than expected).
Fields of papers citing papers by Wei‐Chung Chiang
This network shows the impact of papers produced by Wei‐Chung Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chung Chiang. The network helps show where Wei‐Chung Chiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Chung Chiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor Hit paper breakdown → | 2016 | 663 |
| 2 | Disruption of the beclin 1–BCL2 autophagy regulatory complex promotes longevity in mice Hit paper breakdown → | 2018 | 492 |
| 3 | 2012 | 166 | |
| 4 | 2006 | 77 | |
| 5 | 2005 | 63 | |
| 6 | 2012 | 57 | |
| 7 | 2018 | 57 | |
| 8 | 2011 | 41 | |
| 9 | 2021 | 37 | |
| 10 | 2004 | 25 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 0 |
About Wei‐Chung Chiang
Wei‐Chung Chiang is a scholar working on Molecular Biology, Epidemiology, Aging, Geriatrics and Gerontology and Cell Biology, having authored 13 papers that have together received 1.7k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (7 papers), Genetics, Aging, and Longevity in Model Organisms (4 papers), Mitochondrial Function and Pathology (3 papers), Plant responses to water stress (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), RNA modifications and cancer (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Aging (270 citations), Geriatrics and Gerontology (96 citations), Epidemiology (810 citations), Physiology (85 citations) and Molecular Biology (940 citations). Wei‐Chung Chiang has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Beth Levine, Yongjie Wei, Prashant Mishra, Rhea Sumpter, Ao‐Lin Hsu, Tsui‐Ting Ching, Zhongju Zou, Carol Mousigian, Hee Chul Lee and Ming Chang Hu. Their work appears in journals such as Journal of Biological Chemistry, Cell, IUBMB Life, Clinical Cancer Research and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.